Can-Fite BioPharma American Depositary Shares
CANF
10 hedge funds and large institutions have $710K invested in Can-Fite BioPharma American Depositary Shares in 2015 Q1 according to their latest regulatory filings, with 8 funds opening new positions, increasing their positions, 2 reducing their positions, and 2 closing their positions.
300% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 2
150% more funds holding
Funds holding: 4 → 10 (+6)
0% less ownership
Funds ownership: 0% → 0% (-0%)
67% less capital invested
Capital invested by funds: $2.18M → $710K (-$1.47M)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$337K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
+$204K |
| 3 |
TAM
Taylor Asset Management
Toronto,
Ontario, Canada
|
+$72.1K |
| 4 |
MC
Menta Capital
San Francisco,
California
|
+$48.1K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$36.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ES
Equitec Specialists
Chicago,
Illinois
|
-$1.53M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$445K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$12K |
| 4 |
Morgan Stanley
New York
|
-$5K |
| 5 |
BRWA
B. Riley Wealth Advisors
Boca Raton,
Florida
|
-$4 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
ES
1
Equitec Specialists
Chicago,
Illinois
| $265K | -$1.53M | -127 | -76% |
|
|
2
Renaissance Technologies
New York
| $190K | +$337K | +28 | New |
|
|
VKH
3
Virtu KCG Holdings
New York
| $112K | +$204K | +17 | New |
|
|
TAM
4
Taylor Asset Management
Toronto,
Ontario, Canada
| $42K | +$72.1K | +6 | New |
|
|
MC
5
Menta Capital
San Francisco,
California
| $27K | +$48.1K | +4 | New |
|
|
6
Citadel Advisors
Miami,
Florida
| $23K | +$36.1K | +3 | New |
|
7
Goldman Sachs
New York
| $23K | +$36.1K | +3 | New |
|
|
8
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $16K | -$445K | -37 | -95% |
|
9
UBS Group
Zurich,
Switzerland
| $5K | +$12K | +1 | New |
|
|
MFS
10
MSI Financial Services
Springfield,
Massachusetts
| $4K | +$12K | +1 | New |
|
|
TRCT
11
Tower Research Capital (TRC)
New York
| $2K | -$12K | -1 | Closed |
|
12
Citigroup
New York
| $1K | – | – | – |
|
|
13
Morgan Stanley
New York
| – | -$5K | -1 | Closed |
|
|
BRWA
14
B. Riley Wealth Advisors
Boca Raton,
Florida
| – | -$4 | – | – |
|
CANF Hedge Fund Activity: Q1 2015 in Review
10 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Can-Fite BioPharma American Depositary Shares (CANF) for Q1 2015, worth a combined $710K — down 67% from $2.18M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new CANF positions and 2 closed out — a net gain of 6 holders — while 0 added to existing stakes and 2 trimmed.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $337K. The largest seller was Equitec Specialists, cutting an estimated $1.53M.
- 10 institutional investors held Can-Fite BioPharma American Depositary Shares (CANF) as of Q1 2015, up from 4 in Q4 2014.
- Funds reported $710K of Can-Fite BioPharma American Depositary Shares stock for Q1 2015, down 67% quarter-over-quarter.
- 8 funds opened new Can-Fite BioPharma American Depositary Shares positions in Q1 2015 and 2 closed out, a net change of +6 holders.
- The largest Can-Fite BioPharma American Depositary Shares buyer in Q1 2015 was Renaissance Technologies, an estimated $337K added.
- The largest Can-Fite BioPharma American Depositary Shares seller in Q1 2015 was Equitec Specialists, an estimated $1.53M sold.
Based on aggregated 13F filings for Q1 2015.